文献速递妇科

1996至2023年激素替代治疗使用与停药趋势:威尔士人群观察性研究

Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996-2023: An Observational Study of the Welsh Population.
PubMed 文献 · BJOG · 2025-05-19

基于威尔士SAIL数据库的观察性研究分析1996至2023年口服与经皮激素替代治疗(HRT)处方趋势及一年内停药预测因素。共292707名女性被处方HRT;经皮处方在2021年后指数上升而口服处方在2002年后下降;口服剂型与停药减少相关而经皮剂型与停药增加相关;贫困降低总体HRT处方;2000年后处方预测停药增加,2021年后最高。

要点

  • 1996至2023年威尔士共292707名女性被处方口服或经皮HRT。
  • 经皮HRT处方在2021年后指数上升,口服HRT处方在2002年后下降。
  • 口服剂型与停药减少相关,经皮剂型与停药增加相关。

核心结论

  • HRT处方模式差异反映全科医生和患者对安全性的认知。
  • 40岁中至50岁早期、常处于自然绝经阶段的女性依从性更好,尤其对口服片剂,提示给药途径和症状缓解影响依从性。
  • 社会经济贫困仍是HRT可及性的障碍。
  • 时间趋势凸显广泛宣传的研究和媒体对HRT使用的影响,尽管自2001年以来依从性持续下降。
  • 需要进一步研究以解决社会经济不平等并评估实现成本效益和高效HRT处方策略的方法。

研究设计与样本

  • 使用Secure Anonymised Information Linkage(SAIL)数据库的观察性研究。
  • 数据来自威尔士初级和二级保健,覆盖86%的人口。
  • 评估1996至2023年所有威尔士女性的年度HRT处方率。
  • 在40-65岁女性(n=103114)中评估一年内HRT停药的预测因素,排除卵巢切除、子宫切除或早绝经者。
  • HRT处方率按每1000名女性每年计算,并按HRT类型、年龄组和贫困五分位分层;停药预测因素使用零膨胀负二项回归评估。

主要发现

  • 1996至2023年,威尔士共292707名女性被处方口服或经皮HRT。
  • 经皮处方在2021年后指数上升,而口服处方在2002年后下降。
  • 停药率呈曲线趋势:在40-43岁和50岁中期起增加,在40岁中期至50岁早期减少。
  • 口服剂型与停药减少相关,而经皮剂型显示停药增加。
  • 贫困降低总体HRT处方;2000年后处方预测停药增加,2021年后停药率最高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以解决社会经济不平等并评估实现成本效益和高效HRT处方策略的方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. DESIGN: Observational study using the Secure Anonymised Information Linkage (SAIL) databank. SETTING: Primary and secondary care data from Wales, encompassing 86% of the population. POPULATION: Annual HRT prescription rates from 1996 to 2023 were assessed for all women in Wales. Predictors of HRT discontinuation within one year were assessed in women aged 40-65 (n = 103 114), excluding those with oophorectomy, hysterectomy, or premature menopause. METHODS: HRT prescription rates were calculated per 1000 women per year and stratified by HRT type, age groups and deprivation quintiles. Predictors of discontinuation were assessed using a zero-inflated negative binomial regression. MAIN OUTCOME MEASURES: Annual HRT prescription rates and predictors of discontinuation, including age, deprivation, time period and HRT type. RESULTS: From 1996 to 2023, 292 707 women were prescribed oral or transdermal HRT in Wales. Transdermal prescriptions rose exponentially post-2021, whereas oral prescriptions declined post-2002. Discontinuation rates followed a curvilinear trend: increasing at ages 40-43 and mid-50s onwards and decreasing in mid-40s to early 50s. Oral formats were linked to decreased discontinuation, whereas transdermals showed increased discontinuation. Deprivation reduced HRT prescriptions overall. Prescriptions post-2000 predicted increased discontinuation, with highest rates seen post-2021. CONCLUSIONS: Disparities in HRT prescribing patterns reflect GP and patient perceptions of safety. Women in their mid-40s to early 50s, often at a natural menopause stage, adhered better, particularly to oral tablets, suggesting that administration route and symptom relief influence adherence. Socio-economic deprivation remains a barrier to HRT access. Time trends highlight the influence of widely publicised studies and media on uptake, albeit adherence has continually declined since 2001. Additional research is needed to tackle socio-economic inequalities and assess strategies for achieving cost-effective and efficient HRT prescribing practices.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Andrews R, Lacey A, Bache K, et al. Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996-2023: An Observational Study of the Welsh Population. BJOG. 2025. PMID: 40384462. doi:10.1111/1471-0528.18220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。